MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

DaVita Inc

Geschlossen

BrancheGesundheitswesen

153.69 -0.32

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

151.34

Max

155.24

Schlüsselkennzahlen

By Trading Economics

Einkommen

135M

349M

Verkäufe

35M

3.3B

KGV

Branchendurchschnitt

14.27

63.778

EPS

2.24

Gewinnspanne

10.6

Angestellte

76,000

EBITDA

8.4M

727M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+11.88% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

1. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-2.2B

12B

Vorheriger Eröffnungskurs

154.01

Vorheriger Schlusskurs

153.69

Nachrichtenstimmung

By Acuity

52%

48%

319 / 386 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Neutral Evidence

DaVita Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Feb. 2025, 19:50 UTC

Wichtige Markttreiber

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21. März 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

15. Juli 2024, 08:17 UTC

Market Talk

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Peer-Vergleich

Kursveränderung

DaVita Inc Prognose

Kursziel

By TipRanks

11.88% Vorteil

12-Monats-Prognose

Durchschnitt 172 USD  11.88%

Hoch 184 USD

Tief 165 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für DaVita Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

4 ratings

0

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

150.41 / 153.94Unterstützung & Widerstand

Kurzfristig

Neutral Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

319 / 386 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.